Search Orphan Drug Designations and Approvals
-
Generic Name: | motexafin gadolinium |
---|---|
Date Designated: | 01/27/2003 |
Orphan Designation: | For use in conjunction with whole brain radiation for the treatment of brain metastases arising from solid tumors |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pharmacyclics, LLC 995 E. Arques Avenue Sunnyvale, California 94085 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-